This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Today's Small-Cap Winners and Losers

Odyssey HealthCare (ODSY) was up after the hospice-care company was upgraded by Deutsche Securities to buy from hold. Noting that the company is in the middle of a turnaround, analysts said "we believe (the company's) operational strategy is fundamentally stronger and new senior management should be able to deliver on better (year-over-year) results."

Shares of Odyssey gained $1.31, or 8%, to $17.72.

American Railcar Industries (ARII - Get Report) slipped after the railcar maker said an April 2 tornado had destroyed part of its Marmaduke, Ark., facility. The tornado also destroyed a nearly completed structure that was to receive inbound material and store inventory.

The company said the clean-up of debris is almost finished. American Railcar expects to begin the reconstruction shortly. Also, Morgan Keegan downgraded the stock to market-perform from outperform. Shares dropped $2.71, or 6.9%, to $36.32.

Industrial Services of America (IDSA - Get Report), a logistics-management firm that offers waste and recycling services, jumped more than 50% after the company said its first-quarter earnings rose to $416,526, or 12 cents a share, from $149,088 and 4 cents a share last year.

Revenue for the first quarter fell to $14.5 million from $29.7 million last year because of a reduction in management-fee revenue. Shares of Industrial Services were up $2.61 to $7.58.

Rotech Healthcare (ROHI), a provider of home medical-care services and equipment, was sinking more than 10% after the company's shares were downgraded. CIBC World Markets cut its rating on the stock to sector-underperform from sector perform and said Rotech will probably report a loss for the year.

The downgrade follows an announcement from Rotech last week in which the company said it received Medicare reimbursement payments for compounded budesonide at a lower rate. If the new reimbursement rate is upheld by regulatory authorities, Rotech said it would reduce the company's revenue for 2006 by roughly $30 million and its earnings by 68 cents a share. Shares of Rotech were losing 66 cents to $5.86.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
ARII $58.00 -0.03%
IDSA $4.05 1.20%
TGC $0.27 0.75%
AAPL $125.01 -0.63%
FB $78.10 0.70%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs